LPL Financial LLC Purchases 7,740 Shares of BlackRock Health Sciences Trust (NYSE:BME)

LPL Financial LLC grew its stake in shares of BlackRock Health Sciences Trust (NYSE:BMEFree Report) by 12.5% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 69,587 shares of the company’s stock after purchasing an additional 7,740 shares during the period. LPL Financial LLC’s holdings in BlackRock Health Sciences Trust were worth $2,913,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in BME. Wells Fargo & Company MN boosted its stake in shares of BlackRock Health Sciences Trust by 107.4% in the 4th quarter. Wells Fargo & Company MN now owns 370,553 shares of the company’s stock worth $16,149,000 after buying an additional 191,846 shares during the last quarter. Bank of America Corp DE lifted its position in shares of BlackRock Health Sciences Trust by 4.8% during the fourth quarter. Bank of America Corp DE now owns 145,679 shares of the company’s stock worth $6,349,000 after acquiring an additional 6,727 shares in the last quarter. UBS Group AG lifted its position in shares of BlackRock Health Sciences Trust by 16.7% during the first quarter. UBS Group AG now owns 127,702 shares of the company’s stock worth $5,813,000 after acquiring an additional 18,288 shares in the last quarter. Royal Bank of Canada lifted its position in shares of BlackRock Health Sciences Trust by 7.0% during the third quarter. Royal Bank of Canada now owns 93,007 shares of the company’s stock worth $3,610,000 after acquiring an additional 6,059 shares in the last quarter. Finally, Advisor Group Holdings Inc. increased its holdings in shares of BlackRock Health Sciences Trust by 81.7% in the fourth quarter. Advisor Group Holdings Inc. now owns 90,013 shares of the company’s stock worth $3,923,000 after purchasing an additional 40,475 shares during the period.

BlackRock Health Sciences Trust Price Performance

BME opened at $39.81 on Wednesday. BlackRock Health Sciences Trust has a 52 week low of $38.27 and a 52 week high of $45.50. The business’s fifty day simple moving average is $40.03 and its 200 day simple moving average is $40.76.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th were issued a dividend of $0.213 per share. The ex-dividend date was Monday, August 14th. This represents a $2.56 dividend on an annualized basis and a dividend yield of 6.42%.

BlackRock Health Sciences Trust Profile

(Free Report)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Further Reading

Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BMEFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.